Business Context and Reporting Period
Company: Innate Pharma S.A.
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: September 2021 (Report Date: September 23, 2021)
Principal Executive Office: 117 Avenue de Luminy, 13009 Marseille, France
Key Financial Metrics
The provided filing text is a cover sheet and exhibit index. It does not contain specific financial data. Consequently, the following metrics are not available in this document:
- Revenue
- Profit
- Cash Flow
- Margins
- Debt
- Liquidity
Material Changes
The filing text does not provide comparative financial data or details on material changes versus prior periods. The document serves primarily to transmit a press release (Exhibit 99.1) dated September 23, 2021, the content of which is not included in the input.
Guidance, Outlook, and Risks
The filing text does not contain management commentary, forward-looking guidance, risk factors, contingencies, or descriptions of unusual items. These details would be contained within the referenced press release (Exhibit 99.1), which is not part of the provided text.
Investor Verification Checklist
- Verify the content of the Press Release dated September 23, 2021 (Exhibit 99.1), as the cover sheet contains no operational or financial details.
- Confirm the company's status as a Foreign Private Issuer filing under Form 20-F.
- Review the full text of the press release for any announcements regarding clinical trials, partnerships, or capital raises that may have triggered this filing.